Ambalal Sarabhai Enterprises Ltd.

Financial

	Ambalal Sarabhai Ent	Balaxi Pharma.	Vaidya Sane Ayur Lab
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.01 %	n/a	n/a
Financials
5 yr Average ROE	19.11 %	27.3 %	8.39 %
5yr average Equity Multiplier	2.07	1.4	1.34
5yr Average Asset Turnover Ratio	0.75	1.43	1.57
5yr Avg Net Profit Margin	10.89 %	11.03 %	3.83 %
Price to Book	1.85	1.13	0.0
P/E	20.24	13.95	39.91
5yr Avg Cash Conversion Cycle	-37.53 Days	154.28 Days	-76.76 Days
Inventory Days	33.51 Days	87.41 Days	11.33 Days
Days Receivable	63.69 Days	103.86 Days	24.16 Days
Days Payable	147.98 Days	63.18 Days	116.68 Days
5yr Average Interest Coverage Ratio	9.88	57.05	6.88
5yr Avg ROCE	24.01 %	36.52 %	12.91 %
5yr Avg Operating Profit Margin	5.29 %	16.64 %	7.94 %
5 yr average Debt to Equity	0.32	0.09	0.02
5yr CAGR Net Profit	-30.01 %	-5.76 %	-10.61 %
5yr Average Return on Assets	8.69 %	18.47 %	6.19 %
Shareholdings
Promoter Holding	31.35 %	65.99 %	66.34 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.59 %	-6.87 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Ambalal Sarabhai Ent	Balaxi Pharma.	Vaidya Sane Ayur Lab
Product Wise Break-Up	Product Wise Break-Up Electronics 56.26 Pharmaceutical 43.74 Sale of FMCG Products 0 Sale of Hardware Products 0 Sale of Pharmaceutical Products 0	Product Wise Break-Up Hardware & Accessories Revenue 28.54 Electronics 0 Pharmaceutical 58.85 FMCG 12.61 Pharmaceutical 0	-
Location Wise Break-Up	Location Wise Break-Up India 64.56 Rest of the World 35.44 Guatemala 0 Dominican Republic 0 Angola 0	Location Wise Break-Up Guatemala 29.72 Rest of the World 0 India 0 Angola 21.15 Dominican Republic 22.73 Others 26.4	Location Wise Break-Up Guatemala 0 Rest of the World 0 India 0 Angola 0 Dominican Republic 0 Others 100
Operating Profit Break-Up	Operating Profit Break-Up Electronics 100.0 Pharmaceuticals 0 Sale of Products 0 Hospital Activity 0	-	Operating Profit Break-Up Pharmaceuticals 0 Sale of Products 71.76 Electronics 0 Hospital Activity 28.24
Capex	Capex Pharmaceuticals 57.12 Electronics 42.88 Sale of Products 0 Hospital Activity 0	-	Capex Pharmaceuticals 0 Sale of Products 0 Electronics 0 Hospital Activity 100.0
Asset Break-Up	Asset Break-Up Pharmaceuticals 75.71 Electronics 24.29 Sale of Products 0 Hospital Activity 0	-	Asset Break-Up Pharmaceuticals 0 Sale of Products 0 Electronics 0 Hospital Activity 100.0